Valuation: Dr. Reddy's Laboratories Limited

Market Cap 952B 9.94B 8.74B 8.15B 7.48B 14.01B 14.35B 96.69B 37.81B 471B 37.33B 36.52B 1,629B P/E 2027 *
25.3x
P/E 2028 * 19.7x
Enterprise Value 921B 9.61B 8.45B 7.88B 7.24B 13.54B 13.88B 93.49B 36.56B 456B 36.09B 35.31B 1,575B EV / Sales 2027 *
2.62x
EV / Sales 2028 * 2.29x
Free-Float
70.08%
Yield 2027 *
0.67%
Yield 2028 * 0.74%
1 day+0.66%
1 week-5.25%
Current month-15.75%
1 month-15.32%
3 months-15.62%
6 months-6.62%
Current year-10.06%
1 week 1,080.05
Extreme 1080.05
1,171.2
1 month 1,080.05
Extreme 1080.05
1,389.5
Current year 1,080.05
Extreme 1080.05
1,414.4
1 year 1,080.05
Extreme 1080.05
1,414.4
3 years 1,025.9
Extreme 1025.9
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
Manager TitleAgeSince
Chief Executive Officer 59 30/06/2019
Director of Finance/CFO - 31/07/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 65 01/04/2013
Chairman 58 12/05/2014
Director/Board Member 66 30/01/2019
Date Insider Type Main position Quantity % Market Cap.
01/04/26 Other

Global Head of Quality and PV

35,600 0.0043%
18/12/25 Other

Chairman

85,738,125 10.2732%
18/12/25 Other

Chairman

96,095,920 11.5143%
Change 5-day change 1-year change 3-year change Capi.($)
+0.66%-5.25%-11.14%+2.30% 9.9B
-0.87%+4.04%+58.60%+166.20% 1,089B
-0.45%+3.87%+57.95%+58.50% 643B
+0.04%+3.95%+37.69%+76.03% 465B
-1.69%+8.36%+38.80%+34.26% 359B
-0.51%+3.35%+39.00%+43.76% 303B
+1.50%+5.14%+21.72%+18.77% 267B
+0.79%+4.32%-25.07%-36.02% 226B
-1.39%+5.90%+27.70%+65.55% 212B
-1.18%+1.83%+16.20%+74.32% 167B
Average -0.24%+3.98%+26.14%+50.37% 374.1B
Weighted average by Cap. -0.47%+5.11%+40.88%+80.90%

Financials

2027 *2028 *
Net sales 352B 3.67B 3.23B 3.01B 2.77B 5.18B 5.3B 35.73B 13.97B 174B 13.79B 13.49B 602B 393B 4.1B 3.6B 3.36B 3.09B 5.78B 5.92B 39.88B 15.6B 194B 15.4B 15.06B 672B
Net income 37.27B 389M 342M 319M 293M 548M 562M 3.78B 1.48B 18.44B 1.46B 1.43B 63.75B 49.1B 513M 450M 420M 386M 722M 740M 4.99B 1.95B 24.3B 1.92B 1.88B 84B
Net Debt -31.58B -330M -290M -270M -248M -465M -476M -3.21B -1.25B -15.63B -1.24B -1.21B -54.03B -51.62B -539M -474M -442M -406M -759M -778M -5.24B -2.05B -25.54B -2.02B -1.98B -88.3B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
29/07/26 1,143.20 +0.66% 104,888
28/07/26 ₹1,135.65 -1.33% 103,848
27/07/26 ₹1,150.90 -0.15% 74,148
24/07/26 ₹1,152.60 -1.19% 230,444
23/07/26 ₹1,166.50 -1.39% 395,421
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
40
Last Close Price
1,143.20INR
Average target price
1,262.63INR
Spread / Average Target
+10.45%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DRREDDY Stock